Braxia Scientific Corp Stock Today
| BRAXF Stock | USD 0 0 33.33% |
Performance11 of 100
| Odds Of DistressOver 53
|
Braxia Scientific is trading at 0.004 as of the 27th of November 2024. This is a 33.33% increase since the beginning of the trading day. The stock's lowest day price was 0.004. Braxia Scientific has 53 percent odds of going through some form of financial distress in the next two years but had a very good returns during the last 90 days. Equity ratings for Braxia Scientific Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. Braxia Scientific Corp. is headquartered in Toronto, Ontario. Braxia Scientific operates under Biotechnology classification in the United States and is traded on OTC Exchange.. The company has 240.72 M outstanding shares. More on Braxia Scientific Corp
Moving against Braxia Pink Sheet
Braxia Pink Sheet Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Braxia Scientific Corp [BRAXF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.03 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Braxia Scientific's market, we take the total number of its shares issued and multiply it by Braxia Scientific's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Braxia Scientific Corp classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 240.72 M outstanding shares.
Braxia Scientific Corp has accumulated about 7.68 M in cash with (4.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Braxia Scientific Probability Of Bankruptcy
Ownership AllocationBraxia Scientific holds a total of 240.72 Million outstanding shares. Braxia Scientific Corp shows 11.48 percent of its outstanding shares held by insiders and 0.34 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Braxia Ownership Details
Braxia Scientific Corp Risk Profiles
| Mean Deviation | 12.92 | |||
| Semi Deviation | 12.1 | |||
| Standard Deviation | 22.38 | |||
| Variance | 500.76 |
Braxia Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Braxia Scientific without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Braxia Scientific Corporate Management
| Joshua Rosenblat | Chief Officer | Profile | |
| Roger McIntyre | Chairman CEO | Profile | |
| Stephen Brooks | Chief Officer | Profile | |
| Peter Rizakos | G Counsel | Profile | |
| Jason Wolkove | Chief Officer | Profile |
Other Information on Investing in Braxia Pink Sheet
Braxia Scientific financial ratios help investors to determine whether Braxia Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Braxia with respect to the benefits of owning Braxia Scientific security.